Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trial

the Surgery Under Remimazolam - Total IntraVenous Anaesthesia (SURE-TIVA) Trial Group, J. Fechner*, K. El-Boghdadly, D. R. Spahn, J. Motsch, M. M. R. F. Struys, O. Duranteau, M. T. Ganter, T. Richter, M. W. Hollmann, R. Rossaint, S. Bercker, S. Rex, B. Drexler, F. Schippers, A. Morley, H. Ihmsen, E. Kochs

*Corresponding author voor dit werk

OnderzoeksoutputAcademicpeer review

20 Citaten (Scopus)
26 Downloads (Pure)

Samenvatting

Remimazolam, a short-acting benzodiazepine, may be used for induction and maintenance of total intravenous anaesthesia, but its role in the management of patients with multiple comorbidities remains unclear. In this phase 3 randomised controlled trial, we compared the anaesthetic efficacy and the incidence of postinduction hypotension during total intravenous anaesthesia with remimazolam vs. propofol. A total of 365 patients (ASA physical status 3 or 4) scheduled for elective surgery were assigned randomly to receive total intravenous anaesthesia with remimazolam (n = 270) or propofol (n = 95). Primary outcome was anaesthetic effect, quantified as the percentage of time with Narcotrend® Index values ≤ 60, during surgery (skin incision to last skin suture), with a non-inferiority margin of -10%. Secondary outcome was the incidence of postinduction hypotensive events. Mean (SD) percentage of time with Narcotrend Index values ≤ 60 during surgery across all patients receiving remimazolam (93% (20.7)) was non-inferior to propofol (99% (4.2)), mean difference (97.5%CI) -6.28% (-8.89–infinite); p = 0.003. Mean (SD) number of postinduction hypotension events was 62 (38.1) and 71 (41.1) for patients allocated to the remimazolam and propofol groups, respectively; p = 0.015. Noradrenaline administration events (requirement for a bolus and/or infusion) were also lower in patients allocated to remimazolam compared with propofol (14 (13.5) vs. 20 (14.6), respectively; p < 0.001). In conclusion, in patients who were ASA physical status 3 or 4, the anaesthetic effect of remimazolam was non-inferior to propofol.

Originele taal-2English
Pagina's (van-tot)410-422
Aantal pagina's13
TijdschriftAnaesthesia
Volume79
Nummer van het tijdschrift4
Vroegere onlinedatum14-jan.-2024
DOI's
StatusPublished - apr.-2024

Vingerafdruk

Duik in de onderzoeksthema's van 'Anaesthetic efficacy and postinduction hypotension with remimazolam compared with propofol: a multicentre randomised controlled trial'. Samen vormen ze een unieke vingerafdruk.

Citeer dit